BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17403551)

  • 1. Costs, health effects and cost-effectiveness of alcohol and tobacco control strategies in Estonia.
    Lai T; Habicht J; Reinap M; Chisholm D; Baltussen R
    Health Policy; 2007 Nov; 84(1):75-88. PubMed ID: 17403551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies.
    Ranson MK; Jha P; Chaloupka FJ; Nguyen SN
    Nicotine Tob Res; 2002 Aug; 4(3):311-9. PubMed ID: 12215240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of screening and correcting refractive errors in school children in Africa, Asia, America and Europe.
    Baltussen R; Naus J; Limburg H
    Health Policy; 2009 Feb; 89(2):201-15. PubMed ID: 18621429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol.
    Gordon L; Graves N; Hawkes A; Eakin E
    Chronic Illn; 2007 Jun; 3(2):101-29. PubMed ID: 18083667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of community-based physical activity interventions.
    Roux L; Pratt M; Tengs TO; Yore MM; Yanagawa TL; Van Den Bos J; Rutt C; Brownson RC; Powell KE; Heath G; Kohl HW; Teutsch S; Cawley J; Lee IM; West L; Buchner DM
    Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
    Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
    Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action.
    Bemelmans W; van Baal P; Wendel-Vos W; Schuit J; Feskens E; Ament A; Hoogenveen R
    Prev Med; 2008 Feb; 46(2):127-32. PubMed ID: 17822752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary care.
    Smith MY; Cromwell J; DePue J; Spring B; Redd W; Unrod M
    Manag Care; 2007 Jul; 16(7):48-55. PubMed ID: 17907712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
    Vijgen SM; van Baal PH; Hoogenveen RT; de Wit GA; Feenstra TL
    Health Educ Res; 2008 Apr; 23(2):310-8. PubMed ID: 17675649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling.
    Pinget C; Martin E; Wasserfallen JB; Humair JP; Cornuz J
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):451-5. PubMed ID: 17568248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The costs of smoking and the cost effectiveness of smoking-cessation programs.
    Elixhauser A
    J Public Health Policy; 1990; 11(2):218-37. PubMed ID: 2114423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing tobacco taxes: a cheap tool to increase public health.
    van Baal PH; Brouwer WB; Hoogenveen RT; Feenstra TL
    Health Policy; 2007 Jul; 82(2):142-52. PubMed ID: 17050031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of interventions for reducing road traffic injuries related to driving under the influence of alcohol.
    Ditsuwan V; Lennert Veerman J; Bertram M; Vos T
    Value Health; 2013; 16(1):23-30. PubMed ID: 23337212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis.
    Chisholm D; Rehm J; Van Ommeren M; Monteiro M
    J Stud Alcohol; 2004 Nov; 65(6):782-93. PubMed ID: 15700517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of cardiovascular disease: cost-effectiveness comparison.
    Franco OH; der Kinderen AJ; De Laet C; Peeters A; Bonneux L
    Int J Technol Assess Health Care; 2007; 23(1):71-9. PubMed ID: 17234019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human health benefits from livestock vaccination for brucellosis: case study.
    Roth F; Zinsstag J; Orkhon D; Chimed-Ochir G; Hutton G; Cosivi O; Carrin G; Otte J
    Bull World Health Organ; 2003; 81(12):867-76. PubMed ID: 14997239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of preventive interventions to reduce alcohol consumption in Denmark.
    Holm AL; Veerman L; Cobiac L; Ekholm O; Diderichsen F
    PLoS One; 2014; 9(2):e88041. PubMed ID: 24505370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.
    Floyd K; Hutubessy R; Kliiman K; Centis R; Khurieva N; Jakobowiak W; Danilovits M; Peremitin G; Keshavjee S; Migliori GB
    Eur Respir J; 2012 Jul; 40(1):133-42. PubMed ID: 22362862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The global economic burden of alcohol: a review and some suggestions.
    Baumberg B
    Drug Alcohol Rev; 2006 Nov; 25(6):537-51. PubMed ID: 17132572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.